Zusammenfassung
Zentralvenöse Katheter sind als nichtgetunnelte zentralvenöse Dialysekatheter zur Akutdialyse und als getunnelte Katheter unverzichtbar. Immer häufiger werden sie im Rahmen der Dialyseeinleitung und als intermediärer oder dauerhafter Dialysezugang verwendet, obwohl sie im Vergleich zu nativen Shunts mit erheblichen Risiken (insbesondere der Infektgefährdung und der Induktion von zentralvenösen Stenosen) behaftet sind. Durch schonende Implantationstechniken (Venenpunktion unter sonographischer Kontrolle und Implantation über den Seldingerdraht unter Vermeidung von großlumigen und starren Schleusen), durch verbesserte Hygiene beim Anschluss an die Dialyse und durch moderne Lock-Lösungen lassen sich Komplikationsraten reduzieren.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Allon M (2003) Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36(12): 1539–1544
Allon M (2006) Prophylactic effect of antibiotic lock solution on bacteremia related to use of uncuffed hemodialysis catheters. Nat Clin Pract Nephrol 2(8): 418–419
Allon M, Daugirdas J, Depner TA et al (2006) Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis 47(3): 469–477
Bambauer R, Inniger R, Pirrung KJ et al (1994) Complications and side effects associated with large-bore catheters in the subclavian and internal jugular veins. Artif Organs 18(4): 318–321
Beathard GA (2003) Integrated vascular access management. Blood Purif 21(1): 89–98
Beathard GA, Urbanes A (2008) Infection associated with tunneled hemodialysis catheters. Semin Dial 21(6): 528–538
Bonkain F, Racape J, Goncalvez I et al (2013) Prevention of tunneled cuffed hemodialysis catheter-related dysfunction and bacteremia by a neutral-valve closed-system connector: a single-center randomized controlled trial. Am J Kidney Dis 61(3): 459–465
Cimochowski GE, Worley E, Rutherford WE et al (1990) Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 54(2): 154–161
Dogra GK, Herson H, Hutchison B et al (2002) Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13(8): 2133–2139
Droste JC, Jeraj HA, MacDonald A et al (2003) Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother 51(4): 849–855
Gorke A (2005) Microbial contamination of haemodialysis catheter connections. EDTNA ERCA J 31(2): 79–84
Haage P, Vorwerk D, Piroth W et al (1999) Treatment of hemodialysis-related central venous stenosis or occlusion: results of primary Wallstent placement and follow-up in 50 patients. Radiology 212(1): 175–180
Hemmelgarn BR, Moist LM, Lok CE et al (2011) Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. The New England journal of medicine 364(4): 303–312
Hernandez D, Diaz F, Suria S et al (1993) Subclavian catheter-related infection is a major risk factor for the late development of subclavian vein stenosis. Nephrol Dial Transplant 8(3): 227–230
Hind D, Calvert N, McWilliams R et al (2003) Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 327(7411): 361
Hollenbeck M, Mickely V, Brunkwall J et al (2009) Interdisziplinäre Empfehlungen deutscher Fachgesellschaften zum Gefäßzugang zur Hämodialyse. Nephrologe 4: 158–176
Khanna R, Twardowski ZJ (1996) Recommendations for treatment of exit-site pathology. Perit Dial Int 16 Suppl 3: S100–S104
Landry DL, Braden GL, Gobeille SL et al (2010) Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clinical journal of the American Society of Nephrology : CJASN 5(10): 1799–1804
Mickley V (2001) Stent or bypass? Treatment results in benign central venous obstruction. Zentralbl Chir 126(6): 445–449
Noordzij M, Jager KJ, van der Veer SN et al (2014) Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry. Nephrol Dial Transplant 29(10): 1956–1964
Pastan S, Soucie JM, McClellan WM (2002) Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62(2): 620–626
Pisoni RL, Young EW, Dykstra DM et al (2002) Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61(1): 305–316
Power A, Duncan N, Singh SK et al (2009) Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis 53(6): 1034–1041
Rabe C, Gramann T, Sons X et al (2002) Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Med 28(8): 1172–1176
Ruesch S, Walder B, Tramer MR (2002) Complications of central venous catheters: internal jugular versus subclavian access–a systematic review. Crit Care Med 30(2): 454–460
Schilcher G, Scharnagl H, Horina JH et al (2012) Trisodium citrate induced protein precipitation in haemodialysis catheters might cause pulmonary embolism. Nephrol Dial Transplant 27(7): 2953–2957
Schwab SJ, Quarles LD, Middleton JP et al (1988) Hemodialysis-associated subclavian vein stenosis. Kidney Int 33(6): 1156–1159
Solomon LR, Cheesbrough JS, Ebah L et al (2010) A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis 55(6): 1060–1068
Solomon LR, Cheesbrough JS, Bhargava R et al (2012) Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis. Semin Dial 25(2): 233–238
Spindler B (2004) Vascular access for hemodialysis: the connection for life. Pflege Z 57(2): 89–93
Tordoir J, Canaud B, Haage P et al (2007) EBPG on Vascular Access. Nephrol Dial Transplant 22 Suppl 2: ii88–117
Weijmer MC, Debets-Ossenkopp YJ, Van De Vondervoort FJ et al (2002) Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 17(12): 2189–2195
Weijmer MC, Vervloet MG, ter Wee PM (2004) Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 19(3): 670–677
Weijmer MC, van den Dorpel MA, Van de Ven PJ et al (2005) Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16(9): 2769–2777
Zhao Y, Li Z, Zhang L et al (2014) Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 63(3): 479–490
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Hollenbeck, M., Schindler, R. (2017). Zentralvenöse Katheter zur Akut- und Dauerbehandlung. In: Hepp, W., Koch, M. (eds) Dialyseshunts. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-52699-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-52699-6_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-52698-9
Online ISBN: 978-3-662-52699-6
eBook Packages: Medicine (German Language)